HealthTech

The Howard de Walden Estate has launched a HealthTech development in the Harley Street Health District backed by £52 million investment.

Centred on Hale House, the Portland Place development will be delivered in partnership with Spacemade, a flexible workspace operator, and initially comprise three buildings with a total of 38,000 sq ft.

HdWE aims for Portland Place to emerge as a leading London location for HealthTech startups, investors and venture capital firms.

UCLPartners will be the anchor occupier at Hale House, situated on the first floor at 76-78 Portland Place. UCLPartners is one of the UK’s leading health innovation partnerships, at the forefront of transforming healthcare through collaboration and patient-focused innovations. 

It also oversees delivery of the NHS Innovation Accelerator, which catalyses growth of small enterprise across the NHS. 

London is ‘leading global city for AI businesses to grow’

“The re-launch of the Harley Street Health District marks a natural evolution in our approach to healthcare as we respond to changing patient needs and industry shifts,” said Mark Kildea, CEO at The Howard de Walden Estate.

“Our investment in Hale House and the important signing of UCLPartners is hugely complementary to this strategy and is a key step forward as we look to develop space for health innovation and affirm our commitment to the Harley Street Health District as London’s only cluster of ‘whole health’.”

Chris Laing, CEO at UCLPartners, said: “I am very excited that we are establishing our new base in Hale House as an anchor occupier. I have been very impressed with The Howard De Walden Estate’s ambitious vision to build a world leading health innovation cluster in Marylebone and I’m delighted we are joining them on this journey. 

“UCLPartners works across the health innovation development pipeline, supporting health and economic growth. Our new base will help us connect the health technology and life science sectors with healthcare providers, patients and the public, developing novel solutions that will define the healthcare of the future.”

£105m deal comes FullCircl for Nasdaq-listed nCino